Skip to main content
. Author manuscript; available in PMC: 2022 Dec 22.
Published in final edited form as: Clin Genitourin Cancer. 2021 Aug 16;20(2):97–101. doi: 10.1016/j.clgc.2021.08.001

Table 2.

List of observed mutated genes in extreme responder cohort.

Mutated Gene N (%)
BRCA2 5 (33.3%)
TP53 4 (26.6%)
TP53, BRCA2 2 (13.3%)
TP53, BARD1 1 (6.7%)
BRCA2, ATM 1 (6.7%)
ARID1A 1 (6.7%)
ATM, RB1 1 (6.7%)